This HTML5 document contains 199 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q94484014
rdf:type
wikibase:Item
schema:description
научна статия videnskabelig artikel udgivet maj 2020 2020年学术文章 2020年学术文章 artykuł naukowy scientific article published on 01 May 2020 наукова стаття, опублікована в травні 2020 2020年學術文章 artículo científico publicado en 2020 tudományos cikk სამეცნიერო სტატია vědecký článek 2020年学术文章 artikulong pang-agham vetenskaplig artikel 2020年學術文章 wissenschaftlicher Artikel article scientifique vitskapeleg artikkel مقالة علمية نشرت في مايو 2020 2020年の論文 научни чланак 2020년 논문 article científic naučni članak artigo científico научни чланак bilimsel makale bài báo khoa học scientific article published in May 2020 2020年學術文章 মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ vitenskapelig artikkel vedecký článok article scientific επιστημονικό άρθρο научная статья 2020年學術文章 artikel ilmiah artigo científico 2020年学术文章 tieteellinen artikkeli articolo scientifico artículu científicu 2020 nî lūn-bûn scienca artikolo teaduslik artikkel wetenschappelijk artikel artikull shkencor scientific article published in May 2020 2020年學術文章 מאמר מדעי 2020年学术文章 artigo científico мақолаи илмӣ 2020年学术文章 articol științific
p:P577
wds:Q94484014-255D8F89-7AB7-449F-9C06-5C39706D22E3 wds:Q94484014-B7A0C267-4311-474D-9508-C06E6FB16FAF
wdt:P577
2020-05-01T00:00:00Z 2020-06-01T00:00:00Z
p:P2860
wds:Q94484014-F4B841F1-F4D0-4DBA-AD49-AA5968EE52E1 wds:Q94484014-F8592E06-7272-459F-911A-F5824FCE7CFC wds:Q94484014-FCED0758-707E-4095-A78E-66319C6D0955 wds:Q94484014-FF42CB70-906E-49DD-B1C8-F74A8E95C21A wds:Q94484014-AC87D8E4-E5E8-4F17-B7A8-EEF5310EC778 wds:Q94484014-B004077D-4F80-4500-B813-F3F619CB919A wds:Q94484014-B28A9496-D3CC-4623-8E86-675FE2ACD276 wds:Q94484014-B38AD71E-8204-4150-AA49-6A30BBFE6C64 wds:Q94484014-B5DC50A7-092F-4BF1-9B0D-02DC59380142 wds:Q94484014-C4AAC48A-5B0A-4AB3-A49A-E3B2C5F97FE1 wds:Q94484014-CB10B227-5D42-48B2-91BF-4C2EA95A024F wds:Q94484014-D26406A1-41EB-42C0-9698-473E5D6BD35A wds:Q94484014-EC22F385-C646-4D13-9673-732901E8D734 wds:Q94484014-633D3DE9-87FA-42F9-9AF0-651EC5B81952 wds:Q94484014-64F8BE83-ECDA-466C-8AD6-393790AD6F33 wds:Q94484014-7725AD1A-289E-46D1-B9B5-F7A5778876DF wds:Q94484014-775CA38B-A342-4BD8-A6C3-55DD640F59B9 wds:Q94484014-7CEB9642-23C6-4629-8DCB-5059D419376D wds:Q94484014-92C84D95-1183-431C-A417-3801D2837B79 wds:Q94484014-939C0CA7-3A70-4E43-9F38-A64FB4078F0E wds:Q94484014-A09D1858-8D2E-47F0-BCF4-328B93769147 wds:Q94484014-A0CED8CE-E10C-45B4-A896-D3DE4A111605 wds:Q94484014-A9080C94-236E-48C4-B529-7DCF72339CD9 wds:Q94484014-3ADD71BA-0D9A-4895-B70B-4CEA317AF3B0 wds:Q94484014-3C2C18AB-8F92-4F00-A855-CC12C35DFB2C wds:Q94484014-41B3EF78-A556-4883-B3DF-C92BE93E87DE wds:Q94484014-43CEEFF0-17DF-477F-9CB2-AD1E996DDC5B wds:Q94484014-4738F773-7BB2-4F96-97DF-6AA75EAF5A95 wds:Q94484014-4D386369-C1BB-4810-B668-77CE4F5D50E1 wds:Q94484014-5165CC13-5540-4800-827A-C3D5FAA8271D wds:Q94484014-53E666B9-3F77-4CFA-A103-A3E2AACD6BF3 wds:Q94484014-5877057A-62ED-4092-8661-AAAA61769935 wds:Q94484014-5E2E6102-1754-4C41-8DAD-5F91D39D894C wds:Q94484014-5FACDD82-771E-4D4B-893A-1E8F851CECE8 wds:Q94484014-5FF1D85E-4D87-4D60-B7AC-07D94237A79A wds:Q94484014-61E5B006-3BA4-439F-B7DC-1024E8D942B1 wds:Q94484014-620950F9-0C1F-45EF-A895-358F1D6C4F7A wds:Q94484014-11008B56-E1AB-4EF3-A976-C308557720F6 wds:Q94484014-11BC4182-8CEA-4DB7-A7F9-4731F99350CE wds:Q94484014-1EEDC03F-1950-4B14-8CC9-EDC95F189A34 wds:Q94484014-25F0D91A-DA51-4D47-8FF3-F93B4D0E77B3 wds:Q94484014-275C6F85-4659-48A8-B2B7-F4D421238266 wds:Q94484014-29BDC6C5-179C-483F-BA10-2A3FE745AD96 wds:Q94484014-2F51A49D-6056-4C14-B5D5-74F9E28827D0 wds:Q94484014-32BAD1BE-A556-4BD4-9FA4-394E02055568 wds:Q94484014-3383B43C-4DD8-422A-A26D-57F8253E8CC8
wdt:P2860
wd:Q91465246 wd:Q91861834 wd:Q91465250 wd:Q87281216 wd:Q38077827 wd:Q87865652 wd:Q24235375 wd:Q91214479 wd:Q50099989 wd:Q91875206 wd:Q28072523 wd:Q21144696 wd:Q90031754 wd:Q93097876 wd:Q90296811 wd:Q89934806 wd:Q42223844 wd:Q87461531 wd:Q90232003 wd:Q90061466 wd:Q90174830 wd:Q92119582 wd:Q33397838 wd:Q27021622 wd:Q93136957 wd:Q90156311 wd:Q90252427 wd:Q91283883 wd:Q90237459 wd:Q89794829 wd:Q36190914 wd:Q87412594 wd:Q90464964 wd:Q89746683 wd:Q86921788 wd:Q54205996 wd:Q26749324 wd:Q35920582 wd:Q90167650 wd:Q87412991 wd:Q89589979 wd:Q86910695 wd:Q53132444 wd:Q90067548 wd:Q38081793 wd:Q42227526
p:P2093
wds:Q94484014-7B1F873C-5559-439E-B11D-D2BEE6F5A769 wds:Q94484014-70FF51D4-E3F3-4A05-BB98-13C14149FC2E wds:Q94484014-C2055107-4A59-4D79-A825-0C2FF186E138 wds:Q94484014-ED997B66-324B-4818-89DF-9CAB779901F1 wds:Q94484014-E685531C-118A-4E00-B04F-E3477205EFEF
wdt:P2093
EHA Infectious Disease Scientific Working Group Marie von Lilienfeld-Toal Francesca Compagno Jörg Janne Vehreschild Hans H Hirsch
rdfs:label
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases
skos:prefLabel
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases
schema:name
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases
p:P50
wds:Q94484014-72E0A79E-BB2E-4B54-8791-0FAD7DB86E6A wds:Q94484014-E159B580-42B1-4094-A60D-34A0FD1563FA
wdt:P50
wd:Q88052025 wd:Q57062280
p:P1476
wds:Q94484014-57FC2985-5F0F-4508-AA25-D101007B8A0D
wdt:P1476
Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases
p:P31
wds:Q94484014-2441AB40-163E-4671-A426-C7CE1325C43C wds:Q94484014-b3631425-fb06-4126-8103-459d8533ef06
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q94484014-98F281D7-FD2D-4A1D-98F2-0D593DA7567B wds:Q94484014-6E9BB761-4FF2-4EE4-B3A9-7D2E3F981667 wds:Q94484014-CA9A5B13-9B2C-493D-AE04-48C8A2FAD7FE
wdt:P921
wd:Q64821189 wd:Q82069695 wd:Q1216998
p:P698
wds:Q94484014-A8ED523F-48CD-49B9-89E2-BAEF3C60261D
wdtn:P698
n8:32358568
wdt:P698
32358568
p:P1433
wds:Q94484014-F40F8C47-8555-4C9D-A466-6D661E5177A4
wdt:P1433
wd:Q6534498
p:P356
wds:Q94484014-35AD31A8-2993-4239-98D0-E4E66FC4FAC1
wdtn:P356
n12:S41375-020-0832-Y
wdt:P356
10.1038/S41375-020-0832-Y
p:P6179
wds:Q94484014-0074B0BA-BCF4-4C9B-B31A-BE677CA286B9
wdt:P6179
1127259364
p:P932
wds:Q94484014-D7803682-8A32-4390-9F9A-B27BE1075F0B
wdt:P932
7194246